Alpha & Omega Semiconductor's Omega Labs Achieves SAMHSA Accreditation for Innovative Drug Testing System

Omega Laboratories Achieves SAMHSA Accreditation for Innovative Testing System

Omega Laboratories, Inc., based in Mogadore, Ohio, reaches a significant milestone by securing accreditation from the Substance Abuse and Mental Health Services Administration (SAMHSA). This accreditation, awarded through the National Laboratory Certification Program (NLCP), enables Omega to offer an innovative online Custody and Control Form System (oCCF) tailored for Federally Regulated Drug Testing Programs. This development enhances operational convenience for clients, empowering them to generate essential custody and control forms through their online platform at www.occf.com.

The oCCF system stands out as a versatile tool in the drug testing landscape, accommodating a variety of specimen types, including urine, oral fluid, hair, and breath samples, in addition to point-of-care testing (POCT) devices. This diversity in testing options is crucial for clients seeking comprehensive and flexible drug screening solutions. Jerry Crosby, President of Omega, highlights the accreditation as a testament to the company's expertise in forensic toxicology, emphasizing its commitment to streamlining the testing process for collectors and clinics alike. With over 25 years of experience in advanced specimen analysis, Omega’s SAMHSA accreditation solidifies its position as a trusted partner in the drug testing industry.

Additionally, Omega Laboratories distinguishes itself as the only laboratory in North America to provide the oCCF system in 16 languages, a feature that reflects its dedication to inclusivity and technological advancement. The system’s adaptability, functioning seamlessly with or without Wi-Fi, makes it suitable for various collection scenarios, further enhancing its utility in real-world applications. This accreditation not only reinforces Omega's commitment to excellence but also elevates its reputation as a leader, ensuring accurate and reliable results for all stakeholders involved in drug screening processes.

In a related development, Omega Laboratories' focus on innovation aligns with broader industry trends emphasizing technological enhancements in drug testing. As the sector evolves, laboratories that adopt advanced solutions will likely gain a competitive edge, meeting the increasing demand for reliable and efficient drug screening methods. Omega's recent accreditation positions it favorably within this dynamic landscape, paving the way for future growth and collaboration opportunities in the forensic toxicology field.